|
Bio-Nucleonics
|
|
Bio-Nucleonics Inc. is a privately held, life sciences company located in the United States. The company develops, manufactures, and markets radiopharmaceuticals, medical devices, and imaging agents to detect and treat cardiovascular, oncological, and neurological diseases. Approved by the U.S Food and Drug Administration (FDA), the U.S. Nuclear Regulatory Commission, and the Florida Board of Pharmacy, it is the only U.S. company focused on the development and production of generic radiopharmaceuticals. Regulations The company is regulated by the U.S. Food and Drug Administration (FDA), the U.S. Nuclear Regulatory Commission, the Florida Bureau of Radiation Control, and the Florida Board of Pharmacy. Its products undergo rigorous validation and testing in accordance with current Good Manufacturing Practice, Good Laboratory Practice, and Quality System Requirements. Products and services Bio-Nucleonics' lead product is , which is the generic version of Metastron. Generic Strontium-89 is an option to consider for cancer bone pain therapy. It imitates the behavior of calcium and is preferentially absorbed by bone, concentrating at sites of painful metastatic bone disease. Generic Strontium-89 injection is a pure beta emitter, and selectively irradiates sites of primary and metastatic bone involvement with minimal irradiation of soft tissues distant from bone lesions. Honors and awards Bio-Nucleonics Inc., received the 2009 "Best of Doral Award" in Radioactive Diagnostic Substances, as well as Miami's Beacon Council "Key to the County", in recognition of its importance to the Miami-Dade County economy. 
|
| < Prev | Next > |
|---|
Main Menu
| Home |
| Articles |
| Search |
| Submit Article |
| Contact Us |
| Donate to Wikibin |
